| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cyprus | 22 | 2023 | 79 | 1.560 |
Why?
|
| Diet, Mediterranean | 10 | 2023 | 700 | 1.450 |
Why?
|
| Physical Fitness | 10 | 2022 | 733 | 0.860 |
Why?
|
| Pregnancy Complications | 3 | 2021 | 2862 | 0.770 |
Why?
|
| Metformin | 14 | 2020 | 835 | 0.760 |
Why?
|
| Adiponectin | 4 | 2020 | 1100 | 0.740 |
Why?
|
| Stomach Diseases | 1 | 2020 | 134 | 0.690 |
Why?
|
| Hot Temperature | 2 | 2021 | 1355 | 0.600 |
Why?
|
| Thyroid Diseases | 1 | 2020 | 378 | 0.590 |
Why?
|
| Adolescent Behavior | 4 | 2016 | 1151 | 0.590 |
Why?
|
| Pesticides | 1 | 2019 | 287 | 0.570 |
Why?
|
| Depression | 5 | 2023 | 7767 | 0.570 |
Why?
|
| Life Style | 15 | 2022 | 3835 | 0.550 |
Why?
|
| Hyperlipidemias | 2 | 2020 | 788 | 0.540 |
Why?
|
| Smoking | 8 | 2019 | 8986 | 0.540 |
Why?
|
| Diabetes Mellitus, Type 2 | 20 | 2021 | 11732 | 0.530 |
Why?
|
| Diabetes, Gestational | 8 | 2021 | 1184 | 0.500 |
Why?
|
| Leptin | 3 | 2019 | 1599 | 0.470 |
Why?
|
| Depression, Postpartum | 1 | 2018 | 341 | 0.460 |
Why?
|
| Temperature | 1 | 2019 | 2206 | 0.450 |
Why?
|
| Hydrocortisone | 1 | 2019 | 1826 | 0.410 |
Why?
|
| alpha-Thalassemia | 1 | 2011 | 46 | 0.390 |
Why?
|
| Kuwait | 3 | 2021 | 86 | 0.390 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2016 | 632 | 0.390 |
Why?
|
| Comorbidity | 3 | 2023 | 10387 | 0.380 |
Why?
|
| Occupational Diseases | 5 | 2020 | 1472 | 0.370 |
Why?
|
| Tobacco Use Disorder | 1 | 2016 | 688 | 0.360 |
Why?
|
| Glucose Intolerance | 4 | 2020 | 577 | 0.360 |
Why?
|
| Restaurants | 1 | 2013 | 236 | 0.360 |
Why?
|
| Hypoglycemic Agents | 11 | 2017 | 2875 | 0.350 |
Why?
|
| Cardiovascular Diseases | 20 | 2023 | 15161 | 0.340 |
Why?
|
| Oxidative Stress | 2 | 2023 | 3085 | 0.340 |
Why?
|
| beta-Thalassemia | 1 | 2011 | 225 | 0.330 |
Why?
|
| Cross-Sectional Studies | 23 | 2023 | 25043 | 0.310 |
Why?
|
| Adult | 66 | 2023 | 214035 | 0.310 |
Why?
|
| Tobacco Smoke Pollution | 2 | 2013 | 815 | 0.310 |
Why?
|
| Blood Glucose | 11 | 2017 | 6259 | 0.300 |
Why?
|
| Water Pollutants, Chemical | 4 | 2016 | 311 | 0.300 |
Why?
|
| Police | 2 | 2019 | 149 | 0.290 |
Why?
|
| Body Mass Index | 16 | 2021 | 12718 | 0.290 |
Why?
|
| Sex Hormone-Binding Globulin | 3 | 2020 | 548 | 0.290 |
Why?
|
| Receptors, Adiponectin | 2 | 2020 | 81 | 0.290 |
Why?
|
| Prevalence | 10 | 2020 | 15226 | 0.290 |
Why?
|
| Particulate Matter | 2 | 2021 | 2530 | 0.280 |
Why?
|
| Social Environment | 2 | 2009 | 1023 | 0.280 |
Why?
|
| Risk Reduction Behavior | 5 | 2020 | 1125 | 0.280 |
Why?
|
| Disinfectants | 2 | 2019 | 116 | 0.270 |
Why?
|
| Air Pollution, Indoor | 1 | 2013 | 857 | 0.270 |
Why?
|
| Seasons | 5 | 2021 | 1494 | 0.260 |
Why?
|
| Male | 74 | 2023 | 350027 | 0.260 |
Why?
|
| Trihalomethanes | 2 | 2016 | 23 | 0.260 |
Why?
|
| Female | 70 | 2023 | 380197 | 0.260 |
Why?
|
| Occupational Exposure | 4 | 2019 | 1796 | 0.250 |
Why?
|
| Death, Sudden, Cardiac | 3 | 2018 | 1541 | 0.250 |
Why?
|
| Primary Prevention | 2 | 2017 | 1167 | 0.250 |
Why?
|
| Prediabetic State | 3 | 2019 | 499 | 0.250 |
Why?
|
| Humans | 104 | 2023 | 744220 | 0.250 |
Why?
|
| Hypertension | 4 | 2021 | 8480 | 0.250 |
Why?
|
| Polymorphism, Single Nucleotide | 5 | 2020 | 15525 | 0.240 |
Why?
|
| Hyperglycemia | 1 | 2012 | 1372 | 0.230 |
Why?
|
| Cluster Analysis | 5 | 2020 | 2715 | 0.230 |
Why?
|
| Physical Endurance | 2 | 2019 | 370 | 0.230 |
Why?
|
| Water Supply | 3 | 2014 | 214 | 0.230 |
Why?
|
| Adiposity | 6 | 2021 | 1807 | 0.210 |
Why?
|
| Schools | 3 | 2019 | 1433 | 0.200 |
Why?
|
| Mental Disorders | 1 | 2021 | 6601 | 0.200 |
Why?
|
| Insulin Resistance | 6 | 2015 | 3863 | 0.200 |
Why?
|
| Cross-Over Studies | 4 | 2019 | 2032 | 0.200 |
Why?
|
| Inflammation | 3 | 2023 | 10634 | 0.200 |
Why?
|
| Middle Aged | 53 | 2023 | 213367 | 0.200 |
Why?
|
| Risk Factors | 29 | 2021 | 72280 | 0.200 |
Why?
|
| Diet | 1 | 2019 | 7937 | 0.190 |
Why?
|
| Lung | 1 | 2020 | 9852 | 0.190 |
Why?
|
| Feeding Behavior | 4 | 2022 | 3188 | 0.190 |
Why?
|
| Health Personnel | 4 | 2021 | 3216 | 0.190 |
Why?
|
| Micronutrients | 1 | 2023 | 375 | 0.190 |
Why?
|
| Climate | 1 | 2021 | 147 | 0.180 |
Why?
|
| Adolescent | 19 | 2022 | 85759 | 0.180 |
Why?
|
| Indiana | 4 | 2021 | 92 | 0.180 |
Why?
|
| Phenols | 2 | 2015 | 501 | 0.180 |
Why?
|
| Endocrine System Diseases | 1 | 2022 | 248 | 0.180 |
Why?
|
| Pregnancy | 12 | 2021 | 29142 | 0.180 |
Why?
|
| Young Adult | 16 | 2022 | 56436 | 0.180 |
Why?
|
| Fractures, Compression | 1 | 2021 | 133 | 0.170 |
Why?
|
| Environmental Exposure | 4 | 2015 | 4236 | 0.170 |
Why?
|
| Arsenic | 2 | 2012 | 328 | 0.170 |
Why?
|
| Overweight | 5 | 2019 | 2370 | 0.160 |
Why?
|
| Infant, Small for Gestational Age | 1 | 2021 | 440 | 0.160 |
Why?
|
| Masks | 1 | 2020 | 197 | 0.160 |
Why?
|
| Air Pollutants | 2 | 2023 | 2817 | 0.160 |
Why?
|
| Androgens | 2 | 2016 | 1279 | 0.160 |
Why?
|
| Cultural Diversity | 1 | 2021 | 359 | 0.160 |
Why?
|
| Practice Guidelines as Topic | 2 | 2012 | 7281 | 0.150 |
Why?
|
| Benzhydryl Compounds | 2 | 2015 | 845 | 0.150 |
Why?
|
| Emergencies | 2 | 2018 | 1170 | 0.150 |
Why?
|
| Sleep | 3 | 2021 | 4623 | 0.150 |
Why?
|
| Obesity | 10 | 2022 | 12742 | 0.150 |
Why?
|
| Oxygen Consumption | 3 | 2020 | 1869 | 0.150 |
Why?
|
| Epidemiologic Studies | 1 | 2020 | 676 | 0.150 |
Why?
|
| Exercise Tolerance | 2 | 2012 | 770 | 0.150 |
Why?
|
| Students | 2 | 2019 | 1654 | 0.150 |
Why?
|
| Diabetes Mellitus | 7 | 2019 | 5755 | 0.140 |
Why?
|
| Premature Birth | 2 | 2021 | 1721 | 0.140 |
Why?
|
| Water-Electrolyte Balance | 1 | 2018 | 346 | 0.140 |
Why?
|
| Marketing | 2 | 2009 | 211 | 0.140 |
Why?
|
| Glucuronides | 1 | 2016 | 20 | 0.140 |
Why?
|
| Prospective Studies | 10 | 2021 | 53280 | 0.140 |
Why?
|
| Exercise Test | 6 | 2022 | 2075 | 0.140 |
Why?
|
| Glucose Metabolism Disorders | 1 | 2016 | 54 | 0.140 |
Why?
|
| Anthropometry | 1 | 2020 | 1350 | 0.130 |
Why?
|
| Health Transition | 1 | 2015 | 34 | 0.130 |
Why?
|
| Cohort Studies | 8 | 2021 | 40559 | 0.130 |
Why?
|
| Nursing Staff, Hospital | 1 | 2019 | 346 | 0.130 |
Why?
|
| International Classification of Diseases | 1 | 2020 | 867 | 0.130 |
Why?
|
| Heart Ventricles | 2 | 2018 | 3820 | 0.130 |
Why?
|
| Alanine Transaminase | 2 | 2016 | 592 | 0.130 |
Why?
|
| Albuminuria | 1 | 2019 | 683 | 0.130 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2020 | 738 | 0.120 |
Why?
|
| Spinal Fractures | 1 | 2021 | 696 | 0.120 |
Why?
|
| Risk Assessment | 8 | 2018 | 23337 | 0.120 |
Why?
|
| Estradiol | 2 | 2019 | 2020 | 0.120 |
Why?
|
| Environmental Monitoring | 3 | 2016 | 1414 | 0.120 |
Why?
|
| Subcutaneous Fat | 1 | 2017 | 391 | 0.120 |
Why?
|
| Dental Caries | 1 | 2018 | 415 | 0.120 |
Why?
|
| Hypothyroidism | 1 | 2019 | 659 | 0.120 |
Why?
|
| gamma-Glutamyltransferase | 1 | 2014 | 134 | 0.120 |
Why?
|
| Weight Loss | 4 | 2015 | 2622 | 0.120 |
Why?
|
| Prenatal Care | 2 | 2018 | 1092 | 0.120 |
Why?
|
| Fluid Therapy | 1 | 2018 | 593 | 0.120 |
Why?
|
| Chronic Disease | 3 | 2023 | 9147 | 0.110 |
Why?
|
| Incidence | 12 | 2020 | 20945 | 0.110 |
Why?
|
| Polycarboxylate Cement | 1 | 2013 | 18 | 0.110 |
Why?
|
| Follow-Up Studies | 11 | 2021 | 39045 | 0.110 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2017 | 711 | 0.110 |
Why?
|
| Infection Control | 1 | 2020 | 964 | 0.110 |
Why?
|
| Stillbirth | 1 | 2016 | 346 | 0.110 |
Why?
|
| Antimony | 1 | 2012 | 19 | 0.110 |
Why?
|
| Follistatin | 1 | 2013 | 141 | 0.110 |
Why?
|
| Myostatin | 1 | 2013 | 124 | 0.110 |
Why?
|
| Aspartate Aminotransferases | 1 | 2014 | 418 | 0.110 |
Why?
|
| Genetic Markers | 1 | 2019 | 2634 | 0.110 |
Why?
|
| Activins | 1 | 2013 | 208 | 0.110 |
Why?
|
| Intra-Abdominal Fat | 1 | 2017 | 591 | 0.100 |
Why?
|
| Air Pollutants, Occupational | 1 | 2015 | 408 | 0.100 |
Why?
|
| Lipid Metabolism | 1 | 2020 | 1888 | 0.100 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2016 | 1574 | 0.100 |
Why?
|
| Drinking | 1 | 2013 | 197 | 0.100 |
Why?
|
| Child Mortality | 1 | 2014 | 198 | 0.100 |
Why?
|
| Diabetic Nephropathies | 1 | 2019 | 985 | 0.100 |
Why?
|
| Osteoporosis | 1 | 2021 | 1580 | 0.100 |
Why?
|
| Law Enforcement | 1 | 2013 | 109 | 0.100 |
Why?
|
| Maternal Mortality | 1 | 2014 | 310 | 0.100 |
Why?
|
| Nanoparticles | 1 | 2023 | 1905 | 0.100 |
Why?
|
| Carcinogens, Environmental | 1 | 2011 | 67 | 0.100 |
Why?
|
| Glomerular Filtration Rate | 1 | 2019 | 2170 | 0.100 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2016 | 859 | 0.100 |
Why?
|
| Infant, Newborn | 5 | 2021 | 25618 | 0.100 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2023 | 2103 | 0.090 |
Why?
|
| Chromium | 1 | 2011 | 123 | 0.090 |
Why?
|
| Aged | 23 | 2020 | 163253 | 0.090 |
Why?
|
| Polymerase Chain Reaction | 1 | 2020 | 6172 | 0.090 |
Why?
|
| United States | 14 | 2022 | 69867 | 0.090 |
Why?
|
| Logistic Models | 6 | 2020 | 13409 | 0.090 |
Why?
|
| Diagnostic Self Evaluation | 1 | 2012 | 230 | 0.090 |
Why?
|
| Models, Statistical | 3 | 2021 | 5102 | 0.090 |
Why?
|
| Body Fat Distribution | 1 | 2011 | 244 | 0.090 |
Why?
|
| Fibronectins | 1 | 2013 | 725 | 0.090 |
Why?
|
| Glucose Tolerance Test | 1 | 2012 | 1150 | 0.090 |
Why?
|
| Causality | 1 | 2016 | 1275 | 0.090 |
Why?
|
| Lipids | 1 | 2020 | 3305 | 0.090 |
Why?
|
| Maternal Exposure | 1 | 2016 | 961 | 0.080 |
Why?
|
| Smoking Cessation | 2 | 2013 | 2071 | 0.080 |
Why?
|
| Infant Mortality | 1 | 2014 | 754 | 0.080 |
Why?
|
| Receptors, Leptin | 1 | 2010 | 360 | 0.080 |
Why?
|
| Testosterone | 2 | 2017 | 2411 | 0.080 |
Why?
|
| Risk | 5 | 2015 | 9685 | 0.080 |
Why?
|
| Life Expectancy | 1 | 2015 | 1184 | 0.080 |
Why?
|
| Metabolic Diseases | 1 | 2015 | 658 | 0.080 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2015 | 1261 | 0.080 |
Why?
|
| Massachusetts | 5 | 2021 | 8663 | 0.080 |
Why?
|
| Social Support | 1 | 2018 | 2117 | 0.080 |
Why?
|
| Mass Spectrometry | 1 | 2016 | 2204 | 0.080 |
Why?
|
| Estrogens | 1 | 2015 | 1565 | 0.080 |
Why?
|
| Family Characteristics | 2 | 2013 | 1000 | 0.080 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2018 | 6037 | 0.080 |
Why?
|
| Triglycerides | 4 | 2020 | 2453 | 0.080 |
Why?
|
| Body Weights and Measures | 2 | 2019 | 211 | 0.080 |
Why?
|
| New England | 2 | 2021 | 1022 | 0.080 |
Why?
|
| Health Status | 1 | 2021 | 4034 | 0.080 |
Why?
|
| Cholesterol, HDL | 4 | 2020 | 1814 | 0.080 |
Why?
|
| Medicine, Ayurvedic | 1 | 2007 | 37 | 0.080 |
Why?
|
| Motor Activity | 3 | 2015 | 2714 | 0.070 |
Why?
|
| Hematopoietic System | 1 | 2007 | 109 | 0.070 |
Why?
|
| Body Composition | 2 | 2013 | 2400 | 0.070 |
Why?
|
| Communicable Diseases | 1 | 2015 | 880 | 0.070 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2013 | 3923 | 0.070 |
Why?
|
| Neonatal Screening | 1 | 2011 | 591 | 0.070 |
Why?
|
| Pandemics | 3 | 2021 | 8387 | 0.070 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2021 | 3047 | 0.070 |
Why?
|
| Fasting | 1 | 2012 | 1591 | 0.070 |
Why?
|
| Principal Component Analysis | 2 | 2020 | 940 | 0.070 |
Why?
|
| Sex Factors | 4 | 2019 | 10396 | 0.070 |
Why?
|
| Workload | 1 | 2012 | 850 | 0.070 |
Why?
|
| Employment | 1 | 2013 | 1129 | 0.070 |
Why?
|
| Surgical Procedures, Operative | 1 | 2018 | 1875 | 0.070 |
Why?
|
| Running | 2 | 2021 | 479 | 0.070 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2014 | 1573 | 0.070 |
Why?
|
| Blood Pressure | 6 | 2021 | 8551 | 0.070 |
Why?
|
| Socioeconomic Factors | 4 | 2015 | 7784 | 0.070 |
Why?
|
| Fires | 1 | 2007 | 173 | 0.070 |
Why?
|
| Dehydration | 1 | 2007 | 234 | 0.070 |
Why?
|
| Heart Diseases | 1 | 2018 | 2790 | 0.060 |
Why?
|
| Cholesterol, LDL | 4 | 2020 | 2355 | 0.060 |
Why?
|
| Mass Media | 1 | 2008 | 305 | 0.060 |
Why?
|
| Acute Kidney Injury | 1 | 2018 | 1971 | 0.060 |
Why?
|
| Lead Poisoning | 1 | 2007 | 304 | 0.060 |
Why?
|
| Troponin T | 1 | 2009 | 753 | 0.060 |
Why?
|
| Multivariate Analysis | 5 | 2020 | 12244 | 0.060 |
Why?
|
| School Health Services | 1 | 2008 | 375 | 0.060 |
Why?
|
| Communicable Disease Control | 2 | 2021 | 857 | 0.060 |
Why?
|
| Prenatal Diagnosis | 1 | 2011 | 1236 | 0.060 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2007 | 437 | 0.060 |
Why?
|
| Peer Group | 1 | 2009 | 635 | 0.060 |
Why?
|
| Child | 6 | 2023 | 77679 | 0.060 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2016 | 2408 | 0.060 |
Why?
|
| C-Reactive Protein | 1 | 2015 | 3778 | 0.060 |
Why?
|
| Control Groups | 1 | 2023 | 105 | 0.060 |
Why?
|
| Wounds and Injuries | 1 | 2015 | 2400 | 0.050 |
Why?
|
| Obesity, Morbid | 1 | 2013 | 1213 | 0.050 |
Why?
|
| Linear Models | 3 | 2020 | 5953 | 0.050 |
Why?
|
| Singapore | 1 | 2023 | 295 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3132 | 0.050 |
Why?
|
| Organizational Objectives | 2 | 2014 | 438 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3239 | 0.050 |
Why?
|
| Lead | 1 | 2007 | 854 | 0.050 |
Why?
|
| Quality of Life | 1 | 2023 | 12805 | 0.050 |
Why?
|
| Public Health | 2 | 2012 | 2603 | 0.050 |
Why?
|
| Insulin | 2 | 2014 | 6583 | 0.050 |
Why?
|
| Health Education | 1 | 2008 | 1055 | 0.050 |
Why?
|
| Body Weight | 1 | 2012 | 4666 | 0.050 |
Why?
|
| Peptide Fragments | 1 | 2014 | 5096 | 0.050 |
Why?
|
| Waist-Hip Ratio | 2 | 2014 | 517 | 0.050 |
Why?
|
| Waist Circumference | 2 | 2015 | 917 | 0.050 |
Why?
|
| Creatinine | 2 | 2019 | 1919 | 0.050 |
Why?
|
| Ageusia | 1 | 2020 | 20 | 0.050 |
Why?
|
| Carrier Proteins | 1 | 2013 | 5021 | 0.050 |
Why?
|
| Phenylethyl Alcohol | 1 | 2019 | 13 | 0.040 |
Why?
|
| Urban Population | 2 | 2021 | 2021 | 0.040 |
Why?
|
| Cognition | 1 | 2017 | 6765 | 0.040 |
Why?
|
| Predictive Value of Tests | 2 | 2012 | 15070 | 0.040 |
Why?
|
| Asymptomatic Infections | 1 | 2020 | 128 | 0.040 |
Why?
|
| Occupational Health | 2 | 2019 | 809 | 0.040 |
Why?
|
| Quarantine | 1 | 2021 | 170 | 0.040 |
Why?
|
| Greece | 2 | 2011 | 344 | 0.040 |
Why?
|
| Pilot Projects | 3 | 2019 | 8321 | 0.040 |
Why?
|
| Pharyngitis | 1 | 2020 | 215 | 0.040 |
Why?
|
| Health Surveys | 1 | 2009 | 4037 | 0.040 |
Why?
|
| Sickle Cell Trait | 1 | 2019 | 81 | 0.040 |
Why?
|
| Tyrosine | 1 | 2023 | 1461 | 0.040 |
Why?
|
| Retrospective Studies | 8 | 2021 | 77426 | 0.040 |
Why?
|
| Muscle, Skeletal | 1 | 2013 | 4935 | 0.040 |
Why?
|
| Victoria | 1 | 2018 | 67 | 0.040 |
Why?
|
| Statistics, Nonparametric | 2 | 2017 | 2886 | 0.040 |
Why?
|
| Cystic Fibrosis | 1 | 2007 | 1178 | 0.040 |
Why?
|
| Olfaction Disorders | 1 | 2020 | 222 | 0.040 |
Why?
|
| Nasopharynx | 1 | 2020 | 379 | 0.040 |
Why?
|
| Hospitals, Public | 1 | 2019 | 207 | 0.040 |
Why?
|
| Exercise | 3 | 2021 | 5615 | 0.040 |
Why?
|
| Body Temperature | 1 | 2020 | 777 | 0.040 |
Why?
|
| Transcription Factors | 2 | 2013 | 12207 | 0.040 |
Why?
|
| Regression Analysis | 3 | 2014 | 6461 | 0.040 |
Why?
|
| Neoplasms | 2 | 2019 | 21672 | 0.040 |
Why?
|
| Mass Screening | 1 | 2012 | 5252 | 0.040 |
Why?
|
| Kidney Function Tests | 1 | 2019 | 683 | 0.040 |
Why?
|
| Disease Outbreaks | 2 | 2021 | 1772 | 0.040 |
Why?
|
| Eating | 1 | 2023 | 1538 | 0.040 |
Why?
|
| Heart Rate | 3 | 2012 | 4092 | 0.040 |
Why?
|
| Odds Ratio | 3 | 2020 | 9849 | 0.040 |
Why?
|
| Halogenation | 1 | 2016 | 42 | 0.040 |
Why?
|
| Genetic Variation | 3 | 2019 | 6546 | 0.030 |
Why?
|
| Forced Expiratory Volume | 1 | 2021 | 1744 | 0.030 |
Why?
|
| Age Factors | 3 | 2019 | 18367 | 0.030 |
Why?
|
| Cause of Death | 2 | 2018 | 3584 | 0.030 |
Why?
|
| Health Behavior | 2 | 2019 | 2636 | 0.030 |
Why?
|
| Cholesterol | 2 | 2017 | 2911 | 0.030 |
Why?
|
| Sanitation | 1 | 2015 | 93 | 0.030 |
Why?
|
| Limit of Detection | 1 | 2016 | 265 | 0.030 |
Why?
|
| Autopsy | 1 | 2018 | 1021 | 0.030 |
Why?
|
| Water Purification | 1 | 2014 | 48 | 0.030 |
Why?
|
| Case-Control Studies | 3 | 2018 | 21752 | 0.030 |
Why?
|
| Meta-Analysis as Topic | 1 | 2019 | 1344 | 0.030 |
Why?
|
| Reproducibility of Results | 3 | 2019 | 19907 | 0.030 |
Why?
|
| Food, Preserved | 1 | 2013 | 13 | 0.030 |
Why?
|
| Chi-Square Distribution | 2 | 2011 | 3509 | 0.030 |
Why?
|
| Fever | 1 | 2020 | 1614 | 0.030 |
Why?
|
| Polyethylene Terephthalates | 1 | 2012 | 116 | 0.030 |
Why?
|
| Disinfection | 1 | 2014 | 191 | 0.030 |
Why?
|
| Midwestern United States | 1 | 2012 | 70 | 0.030 |
Why?
|
| Genotype | 3 | 2013 | 12956 | 0.030 |
Why?
|
| Nonlinear Dynamics | 1 | 2015 | 502 | 0.030 |
Why?
|
| Coronary Disease | 1 | 2007 | 6078 | 0.030 |
Why?
|
| Cosmetics | 1 | 2013 | 97 | 0.030 |
Why?
|
| Primary Health Care | 1 | 2008 | 4556 | 0.030 |
Why?
|
| Diet, Reducing | 1 | 2015 | 462 | 0.030 |
Why?
|
| Fibrinogen | 1 | 2015 | 894 | 0.030 |
Why?
|
| Analysis of Variance | 2 | 2011 | 6367 | 0.030 |
Why?
|
| Fatty Acids | 1 | 2019 | 1808 | 0.020 |
Why?
|
| Intention | 1 | 2013 | 341 | 0.020 |
Why?
|
| Proportional Hazards Models | 3 | 2012 | 12355 | 0.020 |
Why?
|
| Ventricular Function, Left | 2 | 2016 | 3669 | 0.020 |
Why?
|
| Neutrophils | 1 | 2023 | 3717 | 0.020 |
Why?
|
| Lipocalins | 1 | 2011 | 170 | 0.020 |
Why?
|
| PPAR gamma | 1 | 2013 | 493 | 0.020 |
Why?
|
| Acute-Phase Proteins | 1 | 2011 | 262 | 0.020 |
Why?
|
| Time Factors | 4 | 2018 | 40063 | 0.020 |
Why?
|
| Patient Compliance | 1 | 2020 | 2684 | 0.020 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2016 | 964 | 0.020 |
Why?
|
| Disease Progression | 2 | 2019 | 13280 | 0.020 |
Why?
|
| Coronary Artery Disease | 1 | 2009 | 6489 | 0.020 |
Why?
|
| Teaching | 1 | 2017 | 1174 | 0.020 |
Why?
|
| Phenotype | 1 | 2007 | 16365 | 0.020 |
Why?
|
| Infant | 3 | 2016 | 35129 | 0.020 |
Why?
|
| Child, Preschool | 3 | 2018 | 40992 | 0.020 |
Why?
|
| Curriculum | 1 | 2022 | 3604 | 0.020 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2015 | 1683 | 0.020 |
Why?
|
| Program Evaluation | 1 | 2017 | 2486 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2019 | 9960 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2016 | 20817 | 0.020 |
Why?
|
| Emergency Medical Technicians | 1 | 2009 | 116 | 0.020 |
Why?
|
| Age Distribution | 1 | 2014 | 2903 | 0.020 |
Why?
|
| Demography | 1 | 2013 | 1656 | 0.020 |
Why?
|
| Birth Weight | 1 | 2016 | 2069 | 0.020 |
Why?
|
| Islets of Langerhans | 1 | 2013 | 1350 | 0.020 |
Why?
|
| Protoporphyrins | 1 | 2007 | 164 | 0.020 |
Why?
|
| Nutritional Status | 1 | 2015 | 1609 | 0.020 |
Why?
|
| Military Personnel | 1 | 2015 | 1133 | 0.020 |
Why?
|
| Alcohol Drinking | 1 | 2019 | 3966 | 0.020 |
Why?
|
| Stress, Psychological | 1 | 2021 | 4245 | 0.020 |
Why?
|
| Pregnancy Outcome | 1 | 2016 | 2796 | 0.020 |
Why?
|
| Quantitative Trait Loci | 1 | 2013 | 2019 | 0.020 |
Why?
|
| Prognosis | 3 | 2019 | 29050 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2023 | 15538 | 0.020 |
Why?
|
| Survival Rate | 1 | 2019 | 12781 | 0.020 |
Why?
|
| Double-Blind Method | 2 | 2009 | 12035 | 0.020 |
Why?
|
| Metabolome | 1 | 2011 | 895 | 0.020 |
Why?
|
| RNA-Binding Proteins | 1 | 2013 | 1903 | 0.020 |
Why?
|
| Body Size | 1 | 2007 | 461 | 0.010 |
Why?
|
| Biliary Fistula | 1 | 1983 | 36 | 0.010 |
Why?
|
| Echocardiography | 1 | 2016 | 5103 | 0.010 |
Why?
|
| Treatment Outcome | 3 | 2017 | 63119 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2018 | 7730 | 0.010 |
Why?
|
| Bronchial Fistula | 1 | 1983 | 85 | 0.010 |
Why?
|
| Complementary Therapies | 1 | 2007 | 486 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2015 | 8628 | 0.010 |
Why?
|
| Population Surveillance | 1 | 2013 | 2616 | 0.010 |
Why?
|
| Task Performance and Analysis | 1 | 2007 | 780 | 0.010 |
Why?
|
| Exercise Therapy | 1 | 2009 | 906 | 0.010 |
Why?
|
| Placebos | 1 | 2007 | 1677 | 0.010 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2014 | 2026 | 0.010 |
Why?
|
| Mutation | 1 | 2007 | 29784 | 0.010 |
Why?
|
| Airway Obstruction | 1 | 1987 | 663 | 0.010 |
Why?
|
| Adipose Tissue | 1 | 2014 | 3278 | 0.010 |
Why?
|
| Thyroidectomy | 1 | 1987 | 879 | 0.010 |
Why?
|
| Alleles | 1 | 2012 | 6938 | 0.010 |
Why?
|
| Research Design | 1 | 2017 | 5987 | 0.010 |
Why?
|
| Hemoglobins | 1 | 2007 | 1533 | 0.010 |
Why?
|
| Health Services Research | 1 | 2008 | 1836 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2019 | 12264 | 0.010 |
Why?
|
| Emergency Medicine | 1 | 2009 | 1207 | 0.010 |
Why?
|
| Patient Education as Topic | 1 | 2009 | 2277 | 0.010 |
Why?
|
| Aged, 80 and over | 3 | 2015 | 57768 | 0.010 |
Why?
|
| Emergency Service, Hospital | 1 | 2018 | 7659 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2011 | 4553 | 0.010 |
Why?
|
| Intubation, Intratracheal | 1 | 1987 | 1357 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2013 | 13036 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2007 | 4188 | 0.010 |
Why?
|
| Electrocardiography | 1 | 2011 | 6442 | 0.010 |
Why?
|
| Anemia | 1 | 2007 | 1504 | 0.010 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 1983 | 949 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2009 | 14726 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2015 | 17449 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2007 | 12961 | 0.010 |
Why?
|
| Registries | 1 | 2007 | 8090 | 0.010 |
Why?
|
| Hospitalization | 1 | 2009 | 10262 | 0.010 |
Why?
|
| Myocardial Infarction | 1 | 2009 | 11728 | 0.000 |
Why?
|
| HIV Infections | 1 | 2014 | 16718 | 0.000 |
Why?
|
| Goiter, Nodular | 1 | 1987 | 24 | 0.000 |
Why?
|
| Tracheotomy | 1 | 1987 | 166 | 0.000 |
Why?
|
| Heart Failure | 1 | 2009 | 10905 | 0.000 |
Why?
|
| Pancreatic Neoplasms | 1 | 1983 | 5257 | 0.000 |
Why?
|
| Graves Disease | 1 | 1987 | 242 | 0.000 |
Why?
|
| Postoperative Complications | 1 | 1987 | 15294 | 0.000 |
Why?
|
| Cholangiography | 1 | 1983 | 189 | 0.000 |
Why?
|
| Carcinoma, Papillary | 1 | 1987 | 783 | 0.000 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 1983 | 504 | 0.000 |
Why?
|
| Pancreatectomy | 1 | 1983 | 804 | 0.000 |
Why?
|
| Bronchoscopy | 1 | 1983 | 862 | 0.000 |
Why?
|
| Pancreas | 1 | 1983 | 1686 | 0.000 |
Why?
|
| Thyroid Neoplasms | 1 | 1987 | 2281 | 0.000 |
Why?
|
| Radiography | 1 | 1983 | 7022 | 0.000 |
Why?
|
| Ultrasonography | 1 | 1983 | 5982 | 0.000 |
Why?
|
| Tomography, X-Ray Computed | 1 | 1983 | 20123 | 0.000 |
Why?
|